# A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

> **NCT06057935** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 64 (estimated)

## Conditions studied

- Malignant Peritoneal Mesothelioma
- Peritoneal Mesothelioma
- Mesothelioma
- Mesothelioma, Malignant
- Malignant Mesothelioma

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Cisplatin
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT06057935
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-21
- **Primary completion:** 2028-09-21
- **Final completion:** 2028-09-21
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06057935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06057935, "A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06057935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*